Vitreous Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion

Ophthalmology

Volumn 116, Issue 1, 2009, Pages 87-93

  Noma, Hidetaka ^a,b   Funatsu, Hideharu ^a   Mimura, Tatsuya ^c   Harino, Seiyo ^d   Hori, Sadao ^e  

^a Tokyo Women s Medical University   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA ISCHEMIA; RETINA MACULA EDEMA; VITRECTOMY; VITREOUS BODY;

AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTERLEUKIN-6; LASER COAGULATION; MACULAR EDEMA; MALE; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY; VITREOUS BODY;

EID: 57949103669     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.09.034     Document Type: Article

References (37)

1. Zegarra H., Gutman F.A., and Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 86 (1979) 1931-1942
2. Hayreh S.S. Classification of central retinal vein occlusion. Ophthalmology 90 (1983) 458-474
3. Gutman F.A., and Zegarra H. Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 28 (1984) 462-470
4. Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 (1994) 1480-1487
5. Chen K.H., Wu C.C., Roy S., et al. Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci 40 (1999) 2627-2632
6. Pe'er J., Folberg R., Itin A., et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105 (1998) 412-416
7. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
8. Vinores S.A., Derevjanik N.L., Ozaki H., et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol 97 (1999) 217-228
9. Gardner T.W., Antonetti D.A., Barber A.J., et al., Penn State Retina Research Group. The molecular structure and function of the inner blood-retinal barrier. Doc Ophthalmol 97 (1999) 229-237
10. Aiello L.P., Northrup J.M., Keyt B.A., et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113 (1995) 1538-1544
11. Cohen T., Nahari D., Cerem L.W., et al. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271 (1996) 736-741
12. Maruo N., Morita I., Shirao M., and Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology 131 (1992) 710-714
13. Noma H., Funatsu H., Yamasaki M., et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140 (2005) 256-261
14. Noma H., Minamoto A., Funatsu H., et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244 (2006) 309-315
15. Noma H., Funatsu H., Yamasaki M., et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22 (2008) 42-48
16. Iturralde D., Spaide R.F., Meyerle C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26 (2006) 279-284
17. Pai S.A., Shetty R., Vijayan P.B., et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 143 (2007) 601-606
18. Tachi N., Hashimoto Y., and Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 97 (1999) 465-469
19. Leizaola-Fernandez C., Suarez-Tata L., and Quiroz-Mercado H. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol [serial online] 2005;5:10. http://www.biomedcentral.com/1471-2415/5/10 Accessed September 13, 2008
20. Baseline and early natural history report: the Central Vein Occlusion Study. Arch Ophthalmol 111 (1993) 1087-1095
21. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology 102 (1995) 1425-1433
22. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 (1997) 486-491
23. Otani T., and Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 129 (2000) 487-494
24. Lutty G.A., McLeod D.S., Merges C., et al. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114 (1996) 971-977
25. Planck S.R., Dang T.T., Graves D., et al. Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci 33 (1992) 78-82
26. Belgore F.M., Blann A.D., Li-Saw-Hee F.L., et al. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am J Cardiol 87 (2001) 805-807 A9
27. Yan S.F., Tritto I., Pinsky D., et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells: central role of the binding site for nuclear factor-IL-6. J Biol Chem 270 (1995) 11463-11471
28. Ali M.H., Schlidt S.A., Chandel N.S., et al. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol 277 (1999) L1057-L1065
29. Pearlstein D.P., Ali M.H., Mungai P.T., et al. Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler Thromb Vasc Biol 22 (2002) 566-573
30. Chahal P.S., Fallon T.J., and Kohner E.M. Measurement of blood-retinal barrier function in central retinal vein occlusion. Arch Ophthalmol 104 (1986) 554-557
31. Tolentino M.J., Miller J.W., Gragoudas E.S., et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103 (1996) 1820-1828
32. Pournaras C.J., Tsacopoulos M., Strommer K., et al. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 97 (1990) 1329-1333
33. Pournaras C.J., Miller J.W., Gragoudas E.S., et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. Arch Ophthalmol 115 (1997) 1553-1558
34. Ogata N., Ando A., Uyama M., and Matsumura M. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 239 (2001) 87-95
35. Itaya M., Sakurai E., Nozaki M., et al. Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. Invest Ophthalmol Vis Sci 48 (2007) 5677-5683
36. Xiao M., McLeod D., Cranley J., et al. Growth factor staining patterns in the pig retina following retinal laser photocoagulation. Br J Ophthalmol 83 (1999) 728-736
37. Er H., Doganay S., Turkoz Y., et al. The levels of cytokines and nitric oxide in rabbit vitreous humor after retinal laser photocoagulation. Ophthalmic Surg Lasers 31 (2000) 479-483